Inhibition of NLRP3 attenuates sodium dextran sulfate-induced inflammatory bowel disease through gut microbiota regulation
Open Access
- 7 February 2023
- journal article
- research article
- Published by Elsevier in Biomedical Journal
- Vol. 46 (5) , 100580
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Experimental Models of Inflammatory Bowel DiseasesCellular and Molecular Gastroenterology and Hepatology, 2015
- Negative regulation of DSS-induced experimental colitis by PILRαInternational Immunology, 2015
- Macrophage Cytokines: Involvement in Immunity and Infectious DiseasesFrontiers in Immunology, 2014
- A Review on Chemical-Induced Inflammatory Bowel Disease Models in RodentsThe Korean Journal of Physiology & Pharmacology, 2014
- Inflammatory bowel disease: PathogenesisWorld Journal of Gastroenterology, 2014
- Health Benefits of Probiotics: A ReviewISRN Nutrition, 2013
- Gut Microbiota and InflammationNutrients, 2011
- The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental ColitisImmunity, 2010
- Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative ColitisJournal of Clinical Microbiology, 2006
- Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approachGut, 2005